CD274 and cervical carcinoma: PD-L1 expression was assessed in 2 cohorts of primary cervical carcinomas (156 SCC and 49 ADC), and matched primary and metastatic tumors (96 SCC and 31 ADC) 66 using the E1L3N clone on an automated Ventana immunostainer.